Patient Participation

Webinar Date/Time: Tuesday, April 30, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

In light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.

Transparent and detailed communication throughout the research process is key for effectively recruiting and retaining patients for clinical trials.

Exploring a human-centered, holistic approach for equitable trial outcomes.

Truly moving the needle in clinical trial diversity comes down to embracing two fundamental pieces of the DE&I puzzle.

Spotlight on poor compliance, access, and usefulness of trial results summaries.

Webinar Date/Time: Thu, Mar 28, 2024 12:00 PM EDT

With inequalities in palliative care provisions, recent study seeks to create a more equitable, diverse, and inclusive framework based on Patient and Public Involvement.

A framework to understand the different approaches of trial matching solutions and the major operational and workflow challenges that all matching solutions share.

An overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.

Webinar Date/Time: Thursday, March 14th, 2024 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET

Webinar Date/Time: Wed, Mar 27, 2024 11:00 AM EDT

Leveraging a “diversity by design” approach can build patient narratives and optimize protocols from the onset.

Webinar Date/Time: Wednesday, February 14th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Webinar Date/Time: Wednesday, January 31st, 2024 at 9am EST | 6am PST | 2pm GMT | 3pm CET

Fostering common eConsent terminologies enriches communication and understanding across all stakeholders.

Webinar Date/Time: Tuesday, February 6th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Industry challenges present an opportunity for innovation and the adoption of new solutions, particularly in addressing barriers related to patient recruitment, engagement, and retention.

To rebuild trust, companies should focus on transparent, neutral content incorporating medical expertise and regularly seeking HCP feedback.

Education and equitable access are key to unlocking its full potential in the present and future.

Patient and public involvement and engagement has been used for applied research projects, including clinical trials, but has been lacking in statistical methodology research.

Unraveling eConsent Ethics Committees and Health Authorities submission document requirements to foster wider adoption.

There is a growing need to refocus efforts on how diversity is achieved in clinical trials, because some are doing it wrong despite their best intentions.

Amid CVS’ surprise exit from the clinical research space and the ensuing broader questions, study investigates the benefits of pharmacy chain involvement—along with the concerns and barriers to adoption.

Webinar Date/Time: Tue, Nov 14, 2023 11:00 AM EST

In this Q&A with Applied Clinical Trials' sister brand, Pharmaceutical Executive, Lofaso discusses marketing strategies for early-stage biotech companies, including how they can effectively recruit patients for their clinical trials.

Bingham discusses the logistical challenges associated with coordinating patient involvement in rare disease clinical trials.

Webinar Date/Time: Thursday, October 12th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Steve Rosenberg, CEO of uMotif gives commentary on providing clinical trial patients with the best experience possible.

Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT